Chapter 22 : Phase Variation of Streptococcus pneumoniae

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Phase Variation of Streptococcus pneumoniae, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555816513/9781555813437_Chap22-1.gif /docserver/preview/fulltext/10.1128/9781555816513/9781555813437_Chap22-2.gif


undergoes spontaneous, reversible phenotypic variation, or phase variation, which is readily visualized as differences in colony morphology. This chapter describes phase variation in , the pneumococcus, and characterizes its relationship to colonization and the pathogenesis of infection. In particular, the focus is on the identification of variably expressed cell surface components as a means of gaining insight into the pathogenesis of pneumococcal disease at a molecular level. is highly proficient at colonization of its human host. The pneumococcus has the capacity to thrive in a number of diverse host environments, including the bloodstream and the mucosal surface of the nasopharynx. As is the case for other respiratory tract pathogens that frequently cause invasive infection, the ability of the pneumococcus to adapt to these varied environments requires changes in the expression of specific cell surface molecules.

Citation: Weiser J. 2006. Phase Variation of Streptococcus pneumoniae, p 268-274. In Fischetti V, Novick R, Ferretti J, Portnoy D, Rood J (ed), Gram-Positive Pathogens, Second Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816513.ch22

Key Concept Ranking

Teichoic Acid
Teichoic Acid Biosynthesis
Enzyme-Linked Immunosorbent Assay
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of FIGURE 1

Colonies of a type 18C clinical isolate of showing phenotypic variation between opaque (solid arrow) and transparent (open arrow) colony forms when viewed with oblique, transmitted illumination on a transparent surface. Magnification, ×240.

Citation: Weiser J. 2006. Phase Variation of Streptococcus pneumoniae, p 268-274. In Fischetti V, Novick R, Ferretti J, Portnoy D, Rood J (ed), Gram-Positive Pathogens, Second Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816513.ch22
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Aricha, B.,, I. Fishov,, Z. Cohen,, N. Sikron,, S. Pesakhov,, I. Khozin-Goldberg,, R. Dagan,, and N. Porat. 2004. Differences in membrane fluidity and fatty acid composition between phenotypic variants of Streptococcus pneumoniae. J. Bacteriol. 186:46384644.
2. Behr, T.,, W. Fischer,, J. Peter-Katalinic,, and H. Egge. 1992. The structure of pneumococcal lipoteichoic acid. Eur. J. Biochem. 207:10631075.
3. Christensen, G.,, L. Baddour,, B. Madison,, J. Parisi,, S. Abraham,, D. Hasty,, J. Lowrance,, J. Josephs,, and W. Simpson. 1990. Colonial morphology of staphylococci on Memphis agar: phase variation of slime production, resistance to beta-lactam antibiotics, and virulence. J. Infect. Dis. 161:11531169.
4. Cundell, D. R.,, J. N. Weiser,, J. Shen,, A. Young,, and E. I. Tuomanen. 1995. Relationship between colonial morphology and adherence of Streptococcus pneumoniae. Infect. Immun. 63:757761.
5. Cundell, D.,, C. Gerard,, I. Idanpaan-Heikkila,, E. Tuomanen,, and N. Gerard. 1996. PAf receptor anchors Streptococcus pneumoniae to activated human endothelial cells. Adv. Exp. Med. Biol. 416:8994.
6. Duthy, T.,, R. Ormsby,, E. Giannakis,, A. Ogunniyi,, U. Stroeher,, J. Paton,, and D. Gordon. 2002. The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15. Infect. Immun. 70:56045611.
7. Fischer, H.,, and A. Tomasz. 1985. Peptidoglycan cross-linking and teichoic acid attachment in Streptococcus pneumoniae. J. Bacteriol. 163:4654.
8. Fischer, W.,, T. Behr,, R. Hartmann,, K. C. J. Peter,, and H. Egge. 1993. Teichoic acid and lipoteichoic acid of Streptococcus pneumoniae possess identical chain structures. A reinvestigation of teichoid acid (C polysaccharide). Eur. J. Biochem. 215:851857.
9. Goldenberg, H.,, T. McCool,, and J. Weiser. 2004. Human IgG2 recognizing phosphorylcholine shows cross-reactivity and evidence for protection against major bacterial pathogens of the human respiratory tract. J. Infect. Dis. 190:12541263.
10. Gosink, K.,, E. Mann,, C. Guglielmo,, E. Tuomanen,, and H. Masure. 2000. Role of novel choline binding proteins in virulence of Streptococcus pneumoniae. Infect. Immun. 68:56905695.
11. Gotschlich, E. C. 1994. Genetic locus for the biosynthesis of the variable portion of Neisseria gonorrhoeae lipooligosaccharide. J. Exp. Med. 180:21812190.
12. Gould, J.,, and J. Weiser. 2001. Expression of C-reactive protein in the human respiratory tract. Infect. Immun. 69:17471754.
13. Gould, J.,, and J. Weiser. 2002. The inhibitory effect of C-reactive protein on bacterial phosphorylcholine-platelet activating factor receptor mediated adherence is blocked by surfactant. J. Infect. Dis. 186:361371.
14. Hakansson, A.,, H. Roche,, S. Mirza,, L. S. McDaniel,, A. Brooks-Walters,, and D. Briles. 2001. Characterization of binding of human lactoferrin to pneumococcal surface protein A. Infect. Immun. 69:33723381.
15. Hammerschmidt, S.,, A. Muller,, H. Sillmann,, M. Muhlenhoff,, R. Borrow,, A. Fox,, J. van Putten,, W. D. Zollinger,, R. Gerardy-Schahn,, and M. Frosch. 1996. Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease. Mol. Microbiol. 20:12111220.
16. Hammerschmidt, S.,, S. R. Talay,, P. Brandtzaeg,, and G. S. Chhatwal. 1997. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol. Microbiol. 25:11131124.
17. Hammerschmidt, S.,, G. Bethe,, P. Remane,, and G. Chhatwal. 1999. Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae. Infect. Immun. 67:16831687.
18. Hegge, F.,, P. Hitchen,, F. Aas,, H. Kristiansen,, C. Lovold,, W. Egge-Jacobsen,, M. Panico,, W. Leong,, V. Bull,, M. Virji,, H. Morris,, A. Dell,, and M. Koomey. 2004. Unique modifications with phosphocholine and phosphoethanolamine define alternate antigenic forms of Neisseria gonorrhoeae type IV pili. Proc. Natl. Acad. Sci. USA 101:1079810803.
19. Janulczyk, R.,, F. Iannelli,, A. Sjöholm,, G. Pozzi,, and L. Björck. 2000. Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function. J. Biol. Chem. 275:3725737263.
20. Jones, G.,, D. Clewell,, L. Charles,, and M. Vickerman. 1996. Multiple phase variation in haemolytic, adhesive and antigenic properties of Streptococcus gordonii. Microbiology 142:181189.
21. Kim, J.,, and J. Weiser. 1998. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J. Infect. Dis. 177:368377.
22. Kim, J.,, W. J. H. Wani,, H. Sørensen,, J. Blom,, and J. Weiser. 1998. Characterization of phenotypic variants of Streptococcus pneumoniae, abstr. B-2, p. 56. Abstr. 98th Gen. Meet. Am. Soc. Microbiol. 1998. American Society for Microbiology, Washington, D.C.
23. Kim, J. O.,, S. Romero-Steiner,, U. Sørensen,, J. Blom,, M. Carvalho,, S. Barnardi,, G. Carlone,, and J. N. Weiser. 1999. Relationship between cell-surface carbohydrates and intrastrain variation on opsonophagocytosis of Streptococcus pneumoniae. Infect. Immun. 67:23272333.
24. King, S.,, K. Hippe,, J. Gould,, D. Bae,, S. Peterson,, R. Cline,, C. Fasching,, E. Janoff,, and J. Weiser. 2004. Phase variable desialylation of host proteins that bind to Streptococcus pneumoniae in vivo and protect the airway. Mol. Microbiol. 54:159171.
25. Leon, M. A.,, and N. M. Young. 1971. Specificity for phosphorylcholine of six murine myeloma proteins reactive with pneumococcus C polysaccharide and beta-lipoprotein. Biochemistry 10:14241429.
26. Lukomski, S.,, K. Nakashima,, I. Abdi,, V. Cipriano,, B. Shelvin,, E. Graviss,, and J. Musser. 2001. Identification and characterization of a second extracellular collagen-like protein made by group A Streptococcus: control of production at the level of translation. Infect. Immun. 69:17291738.
27. MacLeod, C. M.,, and M. R. Krauss. 1950. Relation of virulence of pneumococcal strains for mice to the quantity of capsular polysaccharide formed in vitro. J. Exp. Med. 92:19.
28. McCarty, M. 1966. The nature of the opaque colony variation in group A streptococci. J. Hyg. Camb. 64:185190.
29. McDaniel, L. S.,, J. Yother,, M. Vijayakumar,, L. McGarry,, W. R. Guild,, and D. E. Briles. 1987. Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA). J. Exp. Med. 165:381394.
30. Mold, C.,, S. Nakayama,, T. Holzer,, H. Gewurz,, and T. Du Clos. 1981. C-reactive protein is protective against Streptococcus pneumoniae infection in mice. J. Exp. Med. 154:17031708.
31. Overweg, K.,, C. Pericone,, G. Verhoef,, J. Weiser,, H. Meiring,, A. De Jong,, R. De Groot,, and P. Hermans. 2000. Differential protein expression in phenotypic variants of Streptococcus pneumoniae. Infect. Immun. 68:46044610.
32. Pericone, C.,, D. Bae,, M. Shchepetov,, T. McCool,, and J. Weiser. 2002. Short-sequence tandem and nontandem DNA repeats and endogenous hydrogen peroxide production contribute to genetic instability of Streptococcus pneumoniae. J. Bacteriol. 184:43924399.
33. Pericone, C.,, S. Park,, J. Imlay,, and J. Weiser. 2003. Factors contributing to hydrogen peroxide resistance in Streptococcus pneumoniae include pyruvate oxidase (SpxB) and avoidance of the toxic effects of the Fenton reaction. J. Bacteriol. 185:68156825.
34. Pincus, S. H.,, R. L. Cole,, M. R. Wessels,, M. D. Corwin,, E. Kamanga-Sollo,, S. F. Hayes,, W. Cieplak,, and J. Swanson. 1992. Group B streptococcal variants. J. Bacteriol. 174:37393749.
35. Pincus, S. H.,, R. L. Cole,, E. Kamanga-Sollo,, and S. H. Fischer. 1993. Interaction of group B streptococcal opacity variants with the host defense system. Infect. Immun. 91:37613768.
36. Ring, A.,, J. N. Weiser,, and E. I. Tuomanen. 1998. Pneumococcal penetration of the blood-brain barrier: molecular analysis of a novel re-entry path. J. Clin. Invest. 102: 347360.
37. Rosenow, C.,, P. Ryan,, J. N. Weiser,, S. Johnson,, P. Fontan,, A. Ortqvist,, and H. R. Masure. 1997. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol. Microbiol. 25:819829.
38. Saluja, S. K.,, and J. N. Weiser. 1995. The genetic basis of colony opacity in Streptococcus pneumoniae: evidence for the effect of box elements on the frequency of phenotypic variation. Mol. Microbiol. 16:215227.
39. Serino, L.,, and M. Virji. 2000. Phosphorylcholine decoration of lipopolysaccharide differentiates commensal Neisseriae from pathogenic strains: identification of licA-type genes in commensal Neisseriae. Mol. Microbiol. 35:15501559.
40. Serino, L.,, and M. Virji. 2002. Genetic and functional analysis of the phosphorylcholine moiety of commensal Neisseria lipopolysaccharide. Mol. Microbiol. 43:437448.
41. Sorensen, U. B. S.,, J. Henrichsen,, H.-C. Chen,, and S. C. Szu. 1990. Covalent linkage between the capsular polysaccharide and cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methods. Microb. Pathog. 8:325334.
42. Spellerberg, B.,, D. R. Cundell,, J. Sandros,, B. J. Pearce,, I. Idanpaan-Heikkila,, C. Rosenow,, and H. R. Masure. 1996. Pyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae. Mol. Microbiol. 19:803813.
43. Stern, A.,, and T. F. Meyer. 1987. Common mechanism controlling phase and antigenic variation in pathogenic neisseriae. Mol. Microbiol. 1:512.
44. Szalai, A. J.,, D. E. Briles,, and J. E. Volanakis. 1996. Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae. Infect. Immun. 64:48504853.
45. Szalai, A. J.,, A. Agrawal,, T. J. Greenhough,, and J. E. Volanakis. 1997. C-reactive protein. Immunol. Res. 16: 127136.
46. Tomasz, A. 1981. Surface components of Streptococcus pneumoniae. Rev. Infect. Dis. 3:190210.
47. Tong, H.,, J. Weiser,, M. James,, and T. DeMaria. 2001. Effect of influenza A virus infection on nasopharyngeal colonization and otitis media induced by transparent or opaque phenotypic variants of Streptococcus pneumoniae in the chinchilla model. Infect. Immun. 69:602606.
48. Volanakis, J. E.,, and M. H. Kaplan. 1974. Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes. Requirement for human C1q. J. Immunol. 113:917.
49. Weiser, J.,, D. Bae,, H. Epino,, S. Gordon,, M. Kapoor,, L. Zenewicz,, and M. Shchepetov. 2001. Changes in availability of oxygen accentuate differences in capsular polysaccharide expression by phenotypic variants and clinical isolates of Streptococcus pneumoniae. Infect. Immun. 69:54305439.
50. Weiser, J.,, Z. Markiewicz,, E. Tuomanen,, and J. Wani. 1996. Relationship between phase variation in colony morphology, intrastrain variation in cell wall physiology and nasopharyngeal colonization by Streptococcus pneumoniae. Infect. Immun. 64:22402245.
51. Weiser, J. N. 1998. Phase variation in colony opacity. Microb. Drug Resist. 4:129145.
52. Weiser, J. N.,, R. Austrian,, P. K. Sreenivasan,, and H. R. Masure. 1994. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect. Immun. 62:25822589.
53. Weiser, J. N.,, J. B. Goldberg,, N. Pan,, L. Wilson,, and M. Virji. 1998. The phosphorylcholine epitope undergoes phase variation on a 43 kD protein in Pseudomonas aeruginosa and on pili of pathogenic Neisseria. Infect. Immun. 66:42634267.
54. Weiser, J. N.,, and M. Kapoor. 1999. Effect of intrastrain variation in amount of capsular polysaccharide on the genetic transformation of Streptococcus pneumoniae: implications for virulence studies of encapsulated strains. Infect. Immun. 67:36903692.
55. Weiser, J. N.,, J. M. Love,, and E. R. Moxon. 1989. The molecular mechanism of phase variation of H. influenzae lipopolysaccharide. Cell 59:657665.
56. Weiser, J. N.,, N. Pan,, K. L. McGowan,, D. Musher,, A. Martin,, and J. C. Richards. 1998. Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J. Exp. Med. 187:631640.
57. Weiser, J. N.,, M. Shchepetov,, and S. T. H. Chong. 1997. Decoration of lipopolysaccharide with phosphorylcholine; a phase-variable characteristic of Haemophilus influenzae. Infect. Immun. 65:943950.
58. Yother, J.,, and J. M. White. 1994. Novel surface attachment mechanism of the Streptococcus pneumoniae protein PspA. J. Bacteriol. 176:29762985.
59. Zhang, J.-R.,, I. Idanpaan-Heikkila,, W. Fischer,, and E. Tuomanen. 1999. Pneumococcal licD2 gene is involved in phosphorylcholine metabolism. Mol. Microbiol. 31: 14771488.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error